Introduction – Biomaterials Science: An Evolving, Multidisciplinary Endeavor

[1]  D. Schiedermayer,et al.  The artificial heart as a bridge to transplant: ethical and legal issues at the bedside. , 1989, The Journal of heart transplantation.

[2]  Matthias P. Lutolf,et al.  Designing materials to direct stem-cell fate , 2009, Nature.

[3]  P. Branemark,et al.  Osseointegration of titanium implants. , 1986, Acta orthopaedica Scandinavica.

[4]  Anthony Ratcliffe,et al.  Translation from research to applications. , 2006, Tissue engineering.

[5]  Phillip A Sharp,et al.  Promoting Convergence in Biomedical Science , 2011, Science.

[6]  G. Vunjak‐Novakovic,et al.  Engineering complex tissues. , 2006, Tissue engineering.

[7]  Buddy D Ratner,et al.  The Biocompatibility Manifesto: Biocompatibility for the Twenty-first Century , 2011, Journal of cardiovascular translational research.

[8]  George Q. Daley,et al.  Prospects for Stem Cell-Based Therapy , 2008, Cell.

[9]  Farshid Guilak,et al.  Advanced tools for tissue engineering: scaffolds, bioreactors, and signaling. , 2006, Tissue engineering.

[10]  Michael S. Goldberg,et al.  Nanostructured materials for applications in drug delivery and tissue engineering , 2007, Journal of biomaterials science. Polymer edition.

[11]  A. Khademhosseini,et al.  Microscale technologies for tissue engineering and biology. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[12]  P. Serruys,et al.  Drug-Eluting Stent Update 2007: Part I: A Survey of Current and Future Generation Drug-Eluting Stents: Meaningful Advances or More of the Same? , 2007, Circulation.

[13]  Robert Langer,et al.  Polymeric Biomaterials in Tissue Engineering , 2008, Pediatric Research.

[14]  Larry L Hench,et al.  Third-Generation Biomedical Materials , 2002, Science.

[15]  David J. Mooney,et al.  Inspiration and application in the evolution of biomaterials , 2009, Nature.

[16]  A. Olivi,et al.  Interstitial chemotherapy for malignant gliomas: the Johns Hopkins experience , 2007, Journal of Neuro-Oncology.

[17]  Antonios G Mikos,et al.  Trends in tissue engineering research. , 2006, Tissue engineering.

[18]  R. Langer,et al.  Designing materials for biology and medicine , 2004, Nature.

[19]  P. Serruys,et al.  Drug-Eluting Stent Update 2007: Part II: Unsettled Issues , 2007, Circulation.

[20]  Daniel G. Anderson,et al.  Knocking down barriers: advances in siRNA delivery , 2009, Nature Reviews Drug Discovery.

[21]  David J. Mooney,et al.  Microenvironmental regulation of biomacromolecular therapies , 2007, Nature Reviews Drug Discovery.

[22]  Shiladitya Sengupta,et al.  Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system , 2005, Nature.

[23]  D. Stocum.  Stem cells in CNS and cardiac regeneration. , 2005, Advances in Biochemical Engineering/Biotechnology.

[24]  Antonios G Mikos,et al.  Strategic directions in tissue engineering. , 2007, Tissue engineering.

[25]  M J Lysaght,et al.  Demographic Scope and Economic Magnitude of Contemporary Organ Replacement Therapies , 2000, ASAIO journal.

[26]  Kiki B Hellman,et al.  Editorial: advancing tissue engineering and regenerative medicine. , 2007, Tissue engineering.

[27]  M C Oz,et al.  Long-term use of a left ventricular assist device for end-stage heart failure. , 2001, The New England journal of medicine.

[28]  Donald E. Ingber,et al.  From Cellular Mechanotransduction to Biologically Inspired Engineering , 2010, Annals of Biomedical Engineering.

[29]  W. David Merryman.  Development of a Tissue Engineered Heart Valve for Pediatrics: A Case Study in Bioengineering Ethics , 2008, Sci. Eng. Ethics.